Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Exoskeletons and Wearable Robotics

Episode 22: Recap from RehabWeek Chicago 2025

27 Oct 2025

Description

Join Dr. Tom Sugar (Wearable Robotics Association) and Bobby Marinov (Exoskeleton Report) as we recap RehabWeek 2025, a world leading conference for rehabilitation robotics, medical exoskeletons, and neurotechnology which was held in Chicago this May.In this episode, Tom shares highlights from the exhibition floor, where 6+ societies united to showcase the future of human mobility. Hear firsthand impressions of cutting-edge exoskeletons and rehab technologies from: • RobotCT — lower-limb and pediatric exoskeletons • XoMotion — hands-free self-balancing gait systems • Wandercraft — autonomous walking exoskeletons • NextStep Robotics — powered ankle assistance for drop foot • Fourier Rehab — upper- and lower-limb therapy robots and humanoid assistants • ⚙️ Robotomize — hip, shoulder, and hand rehabilitation devicesPlus, a recap of a powerful moment when content creator Blue Eye Queen stands and walks again for the first time in months using a new hands-free fall-safe mobility device.RehabWeek 2025 was more than a conference, it was a glimpse into how wearable robotics and rehabilitation technology are reshaping independence, recovery, and mobility.⸻🔗 Learn more: https://exoskeletonreport.comWearable Robotics: https://wearablerobotics.com💌 Subscribe to the Weekly Newsletter: Stay updated on exoskeleton news, jobs, and research.☕ Support the Podcast: https://www.patreon.com/exoskeletonreportSpecial thanks to our Patreon supporters for helping make this episode a reality!Support the show

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.